Animal, Bug Bites a Billion-Dollar Burden

Tweet From Our Sponsor 13 Ways to Keep Your Pet Safe Outdoors By Dennis Thompson HealthDay Reporter TUESDAY, Dec. 11, 2018 (HealthDay News) — The bites of insects, spiders and dogs are a $1 billion yearly drain on the U.S. health care system, a new study has calculated. And climate change is only going to make matters worse, researchers contend. Attacks by mountain...
0 comment

Fentanyl Now the No. 1 Opioid OD Killer

Tweet Tardive Dyskinesia Assessment By Steven Reinberg HealthDay Reporter WEDNESDAY, Dec. 12, 2018 (HealthDay News) — As the U.S. opioid epidemic grinds on, fentanyl is fast becoming the main culprit in drug overdose deaths, health officials report. Cocaine and heroin remain the street drugs of choice, but more overdose deaths involve fentanyl, either mixed with...
0 comment

AFM Has Doctors, Families Trying ‘Whatever Works’

Tweet AFMANow.org. LaMay Axton, Southern California. Samuel Dominguez, MD, PhD, Children’s Hospital Colorado, Aurora. Sherri Smith, San Antonio, TX. Dawn Sticklen, Joplin, MO. Mobeen H. Rathore, MD, Wolfson Children’s Hospital, Jacksonville, FL. Cynthia Wang, MD, UT Southwestern Medical Center, Dallas. Neurology: “Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid...
0 comment

With Diabetes, Must You Fast for Blood Tests?

Tweet 6 Tips to Help if You’re Tired of Your Diabetes By Serena Gordon HealthDay Reporter TUESDAY, Dec. 11, 2018 (HealthDay News) — Fasting before a cholesterol blood test is just a nuisance for most people, but for those with diabetes, it can be dangerous. New research shows that up to 22 percent of people with diabetes who fasted for lab tests had a low...
0 comment

Hidden Dangers in Dust

Tweet TUESDAY, Dec. 11, 2018 (HealthDay News) — An antibacterial called triclosan is common in dust and could result in dust-dwelling bacteria becoming antibiotic-resistant, researchers report. “There is this conventional wisdom that says everything that’s in dust is dead, but that’s not actually the case. There are things living in there,” said study leader Erica Hartmann,...
0 comment

Women Often Wait to Call Help in a Heart Attack

Tweet By Amy Norton HealthDay Reporter TUESDAY, Dec. 11, 2018 (HealthDay News) — Women often delay calling for emergency help when heart attack symptoms start, a new study finds. Researchers in Switzerland found that women suffering a heart attack typically waited 37 minutes longer than men before calling an ambulance. And those delays showed no signs of improving...
0 comment

New Exercise Guidelines Urge Everyone: Just Move

Tweet Bradley J. Cardinal, PhD, Oregon State University, Corvallis. Gina Harney, The Fitnessista, Tucson, AZ. Indira Levine, Les Talk, More Training, Capitol Heights, MD. Richard Troiano, PhD, National Cancer Institute, Bethesda, MD. American Journal of Health Promotion: “Prospective analysis of stage-of-exercise movement following mail-delivered, self-instructional exercise packets.” Journal of...
0 comment

Supreme Court Declines Key Planned Parenthood Case

Tweet Dec. 10 2018 — An appeal from Kansas and Louisiana over Medicaid funding for Planned Parenthood has been rejected by the U.S. Supreme Court. The two states were appealing lower court rulings that prevented them from withholding Medicaid money used for health services for low-income women. The money is not used for abortions, the Associated Press reported. Abortion opponents have say Planned...
0 comment

Brain-Eating Amoeba Tied to Tap Water in Neti Pot

Tweet Dec. 10, 2018 — The use of tap water in a nasal-flushing Neti pot likely led to a Seattle woman’s death from a brain-eating amoeba, doctors write in a case study. Instead of using sterile water or saline, it’s believed the 69-year-old woman used tap water she’d put in a filter-equipped pitcher, CBS News reported. The amoeba got into her upper nasal cavity and then into...
0 comment

Drug Halves Recurrence for Common Breast Cancer

Tweet Slideshow: Where Breast Cancer Spreads By Amy Norton HealthDay Reporter WEDNESDAY, Dec. 5, 2018 (HealthDay News) — For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds. The study focused on nearly 1,500 women with early stage breast cancer...
0 comment